Study finds no shortage of misleading HPV vaccine websites

Research published by the Journal of Adolescent Health demonstrates a reality that Big Pharmas Merck & Co. ($MRK) and GlaxoSmithKline ($GSK) have experienced for years: There's an abundance of misinformation circulating about HPV vaccines. A team led by Dr. Linda Fu at George Washington University completed 20 different searches using a variety of terms linked with HPV vaccines and came across 116 websites, 39% of which were critical. In some cases, the misleading or incomplete sites highlighted safety concerns with the vaccines and contended that the vaccines encourage sexual activity, two misperceptions that have hampered uptake and dragged on sales in the vaccine category for some time. More from FierceVaccines

Suggested Articles

Merck’s Keytruda went up against chemo in a head-to-head colorectal cancer battle—and won.

Roche Canada's new innovation challenge to fight COVID-19 has an April 10 deadline and promises up to $100,000 to fund development.

Merck, Eli Lilly and Pfizer have launched or expanded volunteer programs to dedicate medical workers to the COVID-19 effort.